`
Home
Home ยป companies

Social Media Monitoring Page for Arqule

latest blog entries

Loading...
Branding...

latest headlines for company on cafepharma

Encouraging Phase 1 data with lead compound, ARQ 092, to be presented at AACR
Yahoo
Mon, 04/01/13 - 10:58 am
tags: akt protein inhibitor, ARQ092, Arqule, cancer, Daiichi Sankyo
ArQule Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Thu, 03/14/13 - 10:49 am
tags: Arqule, earnings
ArQule enrolls first patient in Phase 3 trial for carcinoma candidate tivantinib
Yahoo/Fly on the Wall
Thu, 01/31/13 - 11:48 am
tags: Arqule, hepatocellular carcinoma, tivantinib
Latest Tivantinib Failure Hits ArQule Despite Its Irrelevance
Seeking Alpha
Tue, 01/15/13 - 12:39 pm
tags: Arqule, colorectal cancer, Daiichi Sankyo, tivantinib
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 01/12/13 - 11:38 am
tags: Arqule, Idenix, Sequenom
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Mon, 12/24/12 - 11:44 am
tags: Arqule, Array Biopharma, Aveo Pharmaceutical, Celldex, Curis, Exelixis, Genmab, Incyte, MorphoSys, Novartis, Seattle Genetics, YM BioSciences
ArQule: An Inexpensive And Well-Financed Oncology Opportunity
Seeking Alpha
Thu, 12/13/12 - 5:29 pm
tags: ARQ-087, Arqule, Daiichi Sankyo
3 Biotechs With Good FDA News
Motley Fool
Wed, 10/17/12 - 11:49 am
tags: Amarin, Arqule, FDA, Threshold Pharmaceuticals
ArQule's Tivantinib Failure And Exelixis' Cabozantinib PDUFA: Is There A Correlation?
Seeking Alpha
Fri, 10/12/12 - 12:17 pm
tags: Arqule, cabozantinib, Exelixis, non-small cell lung cancer, tivantinib
Weekend Recap: Biotech Madness
Seeking Alpha
Sun, 10/07/12 - 11:47 am
tags: Acadia, Aeterna Zentaris, Amarin, Arena Pharmaceuticals, Arqule, Sarepta Therapeutics, Synta Pharmaceuticals
ArQule stock plunges as lung cancer study shelved
Yahoo/AP
Tue, 10/02/12 - 11:25 am
tags: Arqule, Daiichi Sankyo, lung cancer, non-small cell lung cancer, tivantinib
This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib
Motley Fool
Fri, 08/31/12 - 12:27 pm
tags: Arqule, Astellas, lung cancer, Roche, Tarceva, tivantinib
ArQule Shares Drop on Lung Cancer Drug Safety Concern
Minyanville
Wed, 08/29/12 - 12:17 pm
tags: Arqule, lung cancer, tivantinib
3 Innovative Biotech Stocks To Consider Today
Seeking Alpha
Mon, 08/13/12 - 1:36 pm
tags: Arqule, Bayer, Celgene, OncoSec, Onyx
Winners Of ASCO 2012
Seeking Alpha
Mon, 06/11/12 - 6:19 pm
tags: Arqule, Array Biopharma, ASCO, Astex, AstraZeneca, Bristol-Myers Squibb, Curis, Exelixis, GSK, Immunogen, Pfizer, Sanofi, Seattle Genetics, Synta
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3
Seeking Alpha
Mon, 05/28/12 - 11:21 am
tags: Arqule, ASCO, Aveo, Bristol-Myers Squibb, Cyclacel, Sunesis, Synta
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha
Tue, 05/22/12 - 11:25 am
tags: Acadia, Amicus Therapeutics, Anthera, Arqule, Auxilium, Biogen Idec, Biomarin, Celgene, Celsion, ChemoCentryx, Clovis Oncology, Elan, Eli Lilly, EXACT Sciences, Geron, JNJ, Lexicon Pharmaceuticals, Nektar, Pfizer, Vertex Pharmaceuticals, Vical, Zalicus, Ziopharm
ASCO '12 Abstract Dump: Cancer Stocks in Focus
TheStreet.com
Thu, 05/17/12 - 10:35 am
tags: Ariad Pharmaceuticals, Arqule, Array Biopharma, ASCO, Aveo, Exelixis, Oncothyreon, Onyx, Pharmacyclics, Seattle Genetics
Upcoming ASCO Meeting Could Move These Stocks
Seeking Alpha
Wed, 04/04/12 - 8:45 am
tags: Allos, Ariad Pharmaceuticals, Arqule, Array Biopharma, ASCO, Exelixis, ImmunoCellular Therapeutics
Cancer Cures: ASCO Stocks to Give Your Portfolio a Boost
Motley Fool
Sat, 03/24/12 - 11:30 am
tags: Ariad Pharmaceuticals, Arqule, Aveo Pharmaceutical, Celldex, JNJ

Last 30 twitter posts